Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
Evidence-based pharmacogenetic guidelines in the Netherlands
- In: Poster Presentation
- At: Stockholm (Sweden) (2017)
- Type: Poster
- Poster code: P-E-009-Tuesday
- By: CHEUNG, Ka-Chun (Royal Dutch Pharmacists Association, Medicine Information Centre, DEN HAAG, Netherlands)
- Co-author(s): Ka-Chun Cheung: Health research and innovation, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
Marga Nijenhuis: Medicines Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
Mandy Crommentuijn – van Rhenen: Medicines Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands
Inge Holsappel: Medicines Information Centre, Royal Dutch Pharmacists Association, DEN HAAG, Netherlands - Abstract:
Backgrounds
In recent years a number of scientific studies have shown that genetic variation in genes encoding drug transporters and drug metabolic enzymes affects drug disposition leading to under-dosing or overdosing in affected individuals. Drug response is a complex trait with significant interindividual variability. Therefore, application of.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 28 September 2023